Status:
COMPLETED
Study Comparing Two Different Tablet Formulations Of Bosutinib
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This study is comparing 2 formulations of bosutinib in healthy subjects.
Eligibility Criteria
Inclusion
- Men or women of non-childbearing potential, age 18 to 50 years.
Exclusion
- Any significant cardiovascular, renal, hepatic, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00934674
Start Date
July 1 2009
End Date
August 1 2009
Last Update
September 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tacoma, Washington, United States, 98418